Barclays PLC Trillium Therapeutics Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
N/A
-390,496 Closed
0 $0
Q3 2021

Nov 09, 2021
BUY
N/A
378,119 Added 3055.01%
390,496 $6.86 Million
Q2 2021

Aug 13, 2021
BUY
N/A
9,214 Added 291.31%
12,377 $120,000
Q1 2021

May 13, 2021
BUY
N/A
2,966 Added 1505.58%
3,163 $34,000
Q4 2020

Feb 11, 2021
SELL
N/A
-349,103 Reduced 99.94%
197 $3,000
Q3 2020

Nov 12, 2020
SELL
N/A
-134,939 Reduced 27.87%
349,300 $4.96 Million
Q2 2020

Aug 12, 2020
BUY
N/A
353,069 Added 269.17%
484,239 $3.92 Million
Q1 2020

May 13, 2020
BUY
N/A
131,170 New
131,170 $530,000
Q1 2018

May 15, 2018
SELL
N/A
-10,500 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
N/A
10,500
10,500 $76,000

About Trillium Therapeutics Inc.

TRIL Quotes by TradingView
  • Ticker TRIL
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,995,000
  • Market Cap $1.94B
More about TRIL
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email